The hazards of randomized phase II trials

Ann Oncol. 2012 Jan;23(1):7-9. doi: 10.1093/annonc/mdr567.

¹ Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA. Electronic address: primo.lara@ucdmc.ucdavis.edu.
² Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.

No abstract available

Publication types